EFTA00702718.pdf

From: US GIO To: Undisclosed recipients:; Subject: Important message regarding derivative transactions Date: Mon, 18 Mar 2013 12:34:50 +0000 Attachments: 1.DODD FRANK INFORMATION BOOKLET.pdf Inline-Images: image003.png Hi All, We are quickly approaching the May 1st regulatory deadline requiring you to have signed several Dodd Frank documents if you wish to trade derivatives. Please see the letter below detailing the requirements and work with your GI0 Investor to return the documents as soon as possible. Thank you. RLogo2008_1PM_B At J.P. Morgan, we are committed to keeping you fully up-to-date with the implementation of the Dodd- Frank Wall Street Reform and Consumer Protection Act (the Dodd-Frank Act), and how it will impact your trading activities. To that end, in November of 2012 we sent a number of materials to you for review in order to continue trading derivatives products in the new regulatory environment. These include OTC products such as swaps, options, FX and commodity forwards. Some documents are informational or intended for your records, while others require your careful attention. Full details are given below. In addition, if you wish to trade derivatives transactions in the future, or anticipate entering into any rollover trades, please review the following documents. As a reminder, these documents were due to us by February 15, 2013 to allow for enough processing time in advance of the May 1, 2013 deadline for mandatory disclosures and the June 10, 2013 deadline for mandatory clearing of swaps. Processing includes documentation review by J.P. Morgan Supervisory Management, Credit and Legal teams, J.P. Morgan counter-execution of agreements and document processing. At this time, we can no longer guarantee that we will be able to process documents received after February 15, 2013, but we will continue to process documents on a best efforts basis. If your documents are not fully processed prior to May 1, 2013 we will not be able to trade derivatives with you until your documents have been fully processed and you will be subject to a "first-come-first-serve" policy for clearing account set-up if you intend to clear with J.P. Morgan. Documents to complete, sign and return Bilateral Agreement-Please review, then sign and return as soon as possible. This agreement must be completed by all clients who have, or expect to engage in, derivatives transactions. This includes open derivatives positions, rollover trades and any future derivatives transactions. In addition, if you wish to trade derivatives transactions in the future, or anticipate entering into any rollover trades, please review the following documents. As a reminder, these documents were due to us by February 15, 2013. o Client Futures Agreement (including Risk Disclosure) Over-the-Counter Addendum 0 Derivatives Account Application and Agreement: Swaps and Other Contracts EFTA00702718  Standing Instructions Form FIA-ISDA Cleared Derivatives Execution Agreement Regulation T Account Opening Form (optional) A description of each document is found in the Client Information Booklet (see attached). In accordance with the Dodd-Frank regulations, you will begin receiving disclosures related to your derivatives trading account via the email account that you provide in your Bilateral Agreement. If you would like to receive daily mark-to-market disclosures via J.P. Morgan Online, please contact your J.P. Morgan representative. Please don't hesitate to contact your J.P. Morgan representative with any questions you may have, or you can email your inquiry to As always, we thank you for the trust and confidence you have placed in J.P. Morgan. Bank products and services are offered through JPMorgan Chase Bank, N.A. and its affiliates. Securities are offered by J.P. Morgan Securities LLC. member FINRA, NYSE and SIPC. Investment products: Not FDIC Insured • No bank guarantee • May lose value This email is confidential and subject to important disclaimers and conditions including on offers for the purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege, and legal entity disclaimers, available at EFTA00702719